announced that the FDA has approved WEGOVY as the first GLP-1 receptor agonist for adults with Metabolic Dysfunction-associated Steatohepatitis (MASH) who have moderate to advanced fibrosis, excluding In August 2025, Novo Nordisk cirrhosis , in combination with diet and exercise
Additionally, various difficult toxicities associated with MTX such as testicular toxicity, which is regarded as a severe adverse effect that may result in infertility, may limit the drugs therapeutic impact (Howard et al
2 Intracellular GSH production is dispensable for tumor growth in the mouse flank
You can write for FDA-approved weight-loss medications (Wegovy, Saxenda, Contrave, Qsymia) and off-label options like metformin
Mounjaro 5mg Injection (Tirzepatide) is prescribed for the management of Type 2 diabetes and may help control blood sugar levels